Renascience Statistics
Total Valuation
Renascience has a market cap or net worth of JPY 29.12 billion. The enterprise value is 27.32 billion.
Market Cap | 29.12B |
Enterprise Value | 27.32B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Renascience has 12.71 million shares outstanding.
Current Share Class | 12.71M |
Shares Outstanding | 12.71M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 23.76% |
Owned by Institutions (%) | -3.44% |
Float | 9.69M |
Valuation Ratios
The trailing PE ratio is 257.72.
PE Ratio | 257.72 |
Forward PE | n/a |
PS Ratio | 220.63 |
PB Ratio | 16.93 |
P/TBV Ratio | 16.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 241.80 |
EV / Sales | 207.00 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.39
Current Ratio | 12.39 |
Quick Ratio | 12.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.79% and return on invested capital (ROIC) is -6.08%.
Return on Equity (ROE) | 6.79% |
Return on Assets (ROA) | -5.65% |
Return on Invested Capital (ROIC) | -6.08% |
Return on Capital Employed (ROCE) | -10.41% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 4 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Renascience has paid 30.00 million in taxes.
Income Tax | 30.00M |
Effective Tax Rate | 20.98% |
Stock Price Statistics
The stock price has increased by +431.29% in the last 52 weeks. The beta is 2.41, so Renascience's price volatility has been higher than the market average.
Beta (5Y) | 2.41 |
52-Week Price Change | +431.29% |
50-Day Moving Average | 1,538.06 |
200-Day Moving Average | 881.67 |
Relative Strength Index (RSI) | 48.62 |
Average Volume (20 Days) | 1,995,255 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renascience had revenue of JPY 132.00 million and earned 113.00 million in profits. Earnings per share was 8.89.
Revenue | 132.00M |
Gross Profit | 128.00M |
Operating Income | -179.00M |
Pretax Income | 143.00M |
Net Income | 113.00M |
EBITDA | -178.00M |
EBIT | -179.00M |
Earnings Per Share (EPS) | 8.89 |
Balance Sheet
The company has 1.80 billion in cash and n/a in debt, giving a net cash position of 1.80 billion or 141.52 per share.
Cash & Cash Equivalents | 1.80B |
Total Debt | n/a |
Net Cash | 1.80B |
Net Cash Per Share | 141.52 |
Equity (Book Value) | 1.72B |
Book Value Per Share | 135.31 |
Working Capital | 1.72B |
Cash Flow
Operating Cash Flow | -176.00M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 96.97%, with operating and profit margins of -135.61% and 85.61%.
Gross Margin | 96.97% |
Operating Margin | -135.61% |
Pretax Margin | 108.33% |
Profit Margin | 85.61% |
EBITDA Margin | -134.85% |
EBIT Margin | -135.61% |
FCF Margin | n/a |
Dividends & Yields
Renascience does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.39% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Renascience has an Altman Z-Score of 26.14 and a Piotroski F-Score of 2.
Altman Z-Score | 26.14 |
Piotroski F-Score | 2 |